Clinical Trials Logo

Filter by:
NCT ID: NCT05990946 Recruiting - Clinical trials for Postoperative Complications

Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

Brief Summary: This randomized controlled trial aims to evaluate whether active remote symptom monitoring and management via a smartphone app utilizing electronic patient-reported outcomes (ePRO) can improve adherence to prescribed outpatient pulmonary rehabilitation exercises among postsurgical lung cancer patients. Eligible patients will use the app for perioperative care and be randomized to an intervention group receiving ePRO-based symptom monitoring with clinician feedback or a control group receiving ePRO without feedback. The primary outcome is rehabilitation exercise adherence rate over 1 month after discharge. If proven effective, the app-enabled remote rehabilitation model can be scaled up to enhance recovery for more postoperative patients.

NCT ID: NCT05990829 Recruiting - Clinical trials for Diabetic Macular Edema

Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled Trial

Start date: October 1, 2023
Phase: Phase 4
Study type: Interventional

Diabetic macular edema (DME) is the main cause of severe vision loss in diabetic retinopathy. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) and Ozurdex are two safe and effective ways to treat DME. Pars plana vitrectomy is mainly suitable for the treatment of unabsorbed vitreous hemorrhage (VH) and tractional retinal detachment caused by proliferative diabetic retinopathy (PDR). Intraoperative optical coherence tomography (OCT), a diagnostic device, can be used to evaluate the potential condition of the retina. Many patients with PDR have unclear refractive stroma due to VH and other reasons, so preoperative OCT cannot give a clear diagnosis, so the use of intraoperative OCT can judge whether the patients are complicated with DME and give corresponding treatment. The purpose of this study is to explore the prognosis of patients with DME diagnosed by OCT during PPV and treated with PPV combined with aflibercept or PPV combined with Ozurdex, and to observe and compare the postoperative anatomical results, functional results, times of reinjections and the occurrence of adverse events between the two groups, in order to provide accurate treatment for patients, reduce the frequency of postoperative vitreous injection and lighten the burden of patients.

NCT ID: NCT05990803 Recruiting - Cervical Cancer Clinical Trials

A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Cervical Cancer and Other Gynecological Malignancies

Start date: November 6, 2023
Phase: Phase 2
Study type: Interventional

Objective: To explore the efficacy, safety and tolerability of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in patients with recurrent or metastatic cervical cancer and other gynecological malignancies, and to further explore the optimal dose and mode of combination.

NCT ID: NCT05990621 Recruiting - Clinical trials for CD70-positive Advanced Urologic Neoplasms

Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms

Start date: July 31, 2023
Phase: Phase 1
Study type: Interventional

This is a single-arm, open-label, exploratory clinical study to evaluate the safety, tolerability and preliminary efficacy of Anti-CD70 CAR-T cell injection in patients with CD70-positive Advanced Urologic Neoplasms.

NCT ID: NCT05990530 Recruiting - Clinical trials for Brittle Type 1 Diabetes

Allogeneic Transplantation of Expanded Pancreatic Islet Cells

Start date: February 22, 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of allogeneic pancreatic islet cells transplantation in patients with "brittle" type 1 diabetes.

NCT ID: NCT05990517 Recruiting - Clinical trials for Diabetes After Total Pancreatectomy

Autologous Transplantation of Expanded Pancreatic Islet Cells (YD01-2022) in Patients

Start date: February 22, 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the efficacy and safety of autologous transplantation of expanded pancreatic islet cells in patients with diabetes mellitus after total pancreatectomy.

NCT ID: NCT05990504 Recruiting - Labor Analgesia Clinical Trials

The Effect of Dural Puncture Epidural Block Technique on the Effectiveness and Safety of Labor Analgesia

DPE
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Dural Puncture Epidural is a clinical improvement of Combined Spinal-Epidural and is widely used in Maternal.Dural Puncture Epidural Technique improves Labor Analgesia Quality And Safety By Increasing Drug Permeation.This study combines ultrasound real-time guidance technology. This technology ensures the accuracy of intervertebral space positioning and puncture success rate through operational visualization, and reduces the impact of operator proficiency on research results.

NCT ID: NCT05990452 Recruiting - Clinical trials for Advanced Solid Tumor

Phase I/II FIH Study of 9MW2921 in Patients With Advanced Solid Tumors

Start date: August 28, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-label, Phase I-II, first-in-human (FIH) study of 9MW2921 in patients with locally advanced or metastatic solid tumors refractory to all standard therapies. The objective of this study is to evaluate the safety, tolerability, PK, immunogenicity and Preliminary Antitumor Activity of 9MW2921.

NCT ID: NCT05990374 Recruiting - Diabetes Clinical Trials

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The efficacy of long-term treatment with different GLP-1RA (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc.) was evaluated through 1-4 years of follow-up, and the effects of long-term treatment on blood glucose and body fat of patients.

NCT ID: NCT05990257 Recruiting - Regional Anesthesia Clinical Trials

CMRA for US-guided-MWA of Liver Tumors

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Patients with liver tumors who underwent US-guided-MWA of liver tumors were enrolled. These patients were allocated into three groups based on tumor size and number: A, B, and C. Prior to the ablation procedure, Group A patients received a combination of hepatic hilar block (HHB), Transversus abdominis plane block (TAPB), and local anesthesia (LA). Patients in Group B were administered HHB in conjunction with LA, while those in Group C received TAPB and LA. Evaluative parameters included the Numerical Rating Scale (NRS) scores, consumption of morphine, incidence of complications, and factors influencing perioperative pain.